Accessibility Menu
Drug Free Solution logo

Drug Free Solution(OTC) DSOL

Market Cap$113.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-100%
5 Year-99%
1 Year+100%
1 Month+100%
$0.00
+0.00%
+0.00Today
Drug Free Solution last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-17
Drug Free Solution stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+100%USD 0.002026-05-14
1 month+100%USD 0.002026-05-14
3 month-98.97%USD 0.042026-04-15
Year to date-63.64%USD 0.002025-11-10
1 year+100%USD 0.002024-11-19
3 year+100%USD 0.002022-12-30
5 year-99.03%USD 0.042021-07-14
Since inception-99.91%USD 0.452012-11-09

Drug Free Solution Financials at a Glance

Market Cap

$113.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.10

Net Income (TTM)

-$10.59K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-15.86 (Low)

Price

$0.00

Volume

36,693

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.10

Estimated Earnings Date

N/A

DSOL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Drug Free Solution

Drug Free Solution, Inc. is a lifestyle enterprise based in El Segundo, California, dedicated to enhancing emotional well-being. The company specializes in innovative techniques aimed at addiction prevention, personal growth, and overall lifestyle enhancement.

Products and Services
  • Proprietary "Living Breath Process" for emotional health
  • "Living Breath Series" of educational programs and resources
  • Community wellness initiatives through the "Living Breath Project"
Growth Outlook
  • Focus on addiction recovery aligns with increasing national health concerns
  • Potential for expansion into community wellness centers and correctional facilities
  • Growing demand for emotional well-being solutions in the healthcare sector
Financial Highlights
  • Recent quarterly net income of -$8,406 indicates ongoing operational challenges
  • Trailing twelve months show a negative P/E ratio of -16.94
  • Market capitalization stands at approximately $113,361, reflecting investor interest
Drug Free Solution, Inc. operates within the healthcare information services industry, focusing on emotional well-being through its unique methodologies. The company's flagship offering, the "Living Breath Process," integrates self-reflection and guided breathing techniques to address various emotional health needs. Additionally, the "Living Breath Series" provides educational resources that complement the core process, enhancing user engagement and support. The growth outlook for Drug Free Solution, Inc. is promising, particularly as societal awareness of addiction and emotional health continues to rise. The company's initiatives, such as the "Living Breath Project," aim to establish community wellness centers and support networks, which could significantly impact addiction and incarceration rates across the United States. Financially, the company faces challenges, as indicated by the recent quarterly net income of -$8,406. The trailing twelve months reveal a negative P/E ratio of -16.94, suggesting that the company is currently not profitable. However, the market capitalization of approximately $113,361 indicates a level of investor interest that could be leveraged for future growth. Overall, Drug Free Solution, Inc. presents a unique opportunity in the healthcare sector, focusing on emotional well-being and addiction recovery.
AI Generated • Jul 28, 2026

Industry

Healthcare Providers and Services

CEO

Jessica Bass

Headquarters

El Segundo, CA 90245, US

DSOL Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

2.58%

Return on Capital

N/A

Return on Assets

-12.74%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$113.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

283.40M

Volume

36.69K

Avg. Volume

582.429

Financials (TTM)

Gross Profit

-$0.83

Operating Income

-$10.59K

EBITDA

-$250.04K

Operating Cash Flow

-$735.45

Capital Expenditure

-$27.66

Free Cash Flow

-$763.11

Cash & ST Invst.

$7.12

Total Debt

$0.00

Drug Free Solution Performance Analysis

Drug Free Solution annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-05-31USD 0N/A
20232023-05-31USD 0N/A
20242024-05-31USD 0N/A
20252025-05-31USD 0N/A
Drug Free Solution sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22013-11-30N/A
Q32014-02-28-100.0%
Q32021-02-28N/A
Q12024-08-31N/A
Drug Free Solution annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-05-31USD 0.00N/A
20232023-05-31USD -0.00N/A
20242024-05-31USD 0.00N/A
20252025-05-31USD 0.00N/A
Drug Free Solution sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22013-11-30-100.0%
Q32014-02-288.3%
Q32021-02-28N/A
Q12024-08-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$113.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$56.70K

N/A

Employees

2

N/A

Net Income

-$8.41K

-16548.8%

EBITDA

-$8.41K

+83.3%

Quarterly Fundamentals

Name
Q1 2024YOY CHG

Total Cash

$7.12

-72.8%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-12.74%

N/A

Return on Invested Capital

2.38%

N/A

Free Cash Flow

-$102.51

-185.5%

Operating Cash Flow

-$102.51

-179.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AHGIFAlternate Health Corp.
$0.00+0.00%
SEOVFSernova Corp.
$0.07-15.92%
RDGLVivos Inc.
$0.06+6.29%
ITHUFiAnthus Capital Holdings, Inc.
$0.00+3.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.61-0.02%
SPCXSpace Exploration Technologies
$146.23+0.04%
IPSTIp Strategy
$7.39+2.36%
NVDANvidia
$225.01-0.00%

Questions About DSOL

What is the current price of Drug Free Solution?

Drug Free Solution is trading at $0.00 per share.

What is the 52-week range for Drug Free Solution?

Over the past 52 weeks, Drug Free Solution has traded between $0.00 and $0.10.

How much debt does Drug Free Solution have?

As of the most recent reporting period, Drug Free Solution reported total debt of $0.00.

How much cash does Drug Free Solution have on hand?

Drug Free Solution reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Drug Free Solution’s dividend yield?

Drug Free Solution does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.